Missouri City, TX, United States of America

Feng Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Core Laboratories, Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Feng Li in Subterranean Applications

Introduction

Feng Li is an accomplished inventor based in Missouri City, Texas. He has made significant contributions to the field of subterranean applications through his innovative work. His expertise and creativity have led to the development of a unique patent that showcases his skills as an inventor.

Latest Patents

Feng Li holds a patent for "Oligonucleotide-containing tracer particles for subterranean applications." This invention involves a tracer particle that includes a silica core and a plurality of polymer-coated oligonucleotides. These oligonucleotides are either disposed within the silica core, on the surface of the silica core, or a combination of both. Each polymer-coated oligonucleotide comprises a polymer that at least partially surrounds an oligonucleotide. This innovative approach has the potential to enhance various subterranean applications.

Career Highlights

Feng Li is currently employed at Core Laboratories, Inc., where he continues to push the boundaries of innovation. His work at this esteemed company allows him to collaborate with other talented professionals in the field.

Collaborations

One of his notable coworkers is Joshua C Falkner, with whom he shares insights and ideas that contribute to their innovative projects.

Conclusion

Feng Li's contributions to the field of subterranean applications through his patent demonstrate his commitment to innovation and excellence. His work at Core Laboratories, Inc. highlights the importance of collaboration in driving advancements in technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…